Immunocore Holdings (IMCR) Interest Coverage Ratio (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly Interest Coverage Ratio came in at 2.39 in Q1 2026, up 299.61% year-on-year from 0.6 in Q1 2025, and up 137.0% quarter-over-quarter from 6.45 in Q4 2025.
Immunocore Holdings (IMCR) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Interest Coverage Ratio across 4 years of filings, most recently posting 2.39 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 2.39, up 299.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.83 (down 10.64% YoY), and the FY2025 annual result was 3.73, changed 0.3% from the prior year.
- Interest Coverage Ratio came in at 2.39 for Q1 2026 at Immunocore Holdings, up from 6.45 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.39 in Q1 2026 to a low of 13.03 in Q4 2023.
- The 4-year median for Interest Coverage Ratio is 4.89 (2025), against an average of 5.8.
- Across the five-year window, Interest Coverage Ratio plunged 133.36% in 2025 and surged 299.61% in 2026, its largest moves.
- Immunocore Holdings' Interest Coverage Ratio stood at 13.03 in 2023, then surged by 78.78% to 2.76 in 2024, then slumped by 133.36% to 6.45 in 2025, then soared by 137.0% to 2.39 in 2026.
- The last three Interest Coverage Ratio figures came in at 2.39 (Q1 2026), 6.45 (Q4 2025), and 2.36 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | -258.33 |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | - |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | 11.79 |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 2.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 |
| Dec 31, 2025 | -6.45 |
| Sep 30, 2025 | -2.36 |
| Jun 30, 2025 | -4.89 |
| Mar 31, 2025 | -1.20 |
| Dec 31, 2024 | -2.76 |
| Sep 30, 2024 | -1.98 |
| Jun 30, 2024 | -3.74 |
| Mar 31, 2024 | -8.18 |
| Dec 31, 2023 | -13.03 |
| Sep 30, 2023 | -10.71 |
| Jun 30, 2023 | -10.80 |
| Mar 31, 2023 | -11.76 |